{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=No+instillation", "query": { "intervention": "No instillation" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 32, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=No+instillation&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-12T02:31:10.833Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04246996", "title": "Gentamicin Intravesical Efficacy for Infection of Urinary Tract", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postoperative Urinary Tract Infection", "Pelvic Organ Prolapse", "Stress Urinary Incontinence" ], "interventions": [ { "name": "gentamicin sulfate", "type": "DRUG" }, { "name": "Catheter clamping only", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 370, "start_date": "2020-01-29", "completion_date": "2021-12-05", "has_results": true, "last_update_posted_date": "2022-11-08", "last_synced_at": "2026-09-12T02:31:10.833Z", "location_count": 2, "location_summary": "La Jolla, California • San Diego, California", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04246996" }, { "nct_id": "NCT00003725", "title": "Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "valrubicin", "type": "DRUG" }, { "name": "conventional surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Anthra Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "1996-12", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-11-06", "last_synced_at": "2026-09-12T02:31:10.833Z", "location_count": 51, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 43 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003725" }, { "nct_id": "NCT00569530", "title": "Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction)", "Bronchopulmonary Dysplasia" ], "interventions": [ { "name": "Infasurf (ONY Inc.)", "type": "DRUG" }, { "name": "Sham", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roberta Ballard", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Days", "maximum_age": "14 Days", "sex": "ALL", "summary": "7 Days to 14 Days" }, "enrollment_count": 85, "start_date": "2008-01", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2021-05-11", "last_synced_at": "2026-09-12T02:31:10.833Z", "location_count": 9, "location_summary": "Berkeley, California • Oakland, California • San Francisco, California + 5 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00569530" }, { "nct_id": "NCT00462488", "title": "Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Urinary Bladder Cancer", "Bladder Cancer", "Bladder Neoplasms", "Bladder Tumors" ], "interventions": [ { "name": "Vicinium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sesen Bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2007-03", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2020-05-12", "last_synced_at": "2026-09-12T02:31:10.833Z", "location_count": 8, "location_summary": "Tallahassee, Florida • Baltimore, Maryland • Lawrenceville, New Jersey + 5 more", "locations": [ { "city": "Tallahassee", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Lawrenceville", "state": "New Jersey" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Springfield", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00462488" }, { "nct_id": "NCT01711593", "title": "Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma", "Allergies" ], "interventions": [ { "name": "Bronchoscopy, Segmental Allergen Challenge and Bronchoalveolar Lavage", "type": "BIOLOGICAL" }, { "name": "Phlebotomy", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE" ], "sponsor": "Andrew D. Luster, M.D.,Ph.D.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 43, "start_date": "2013-01", "completion_date": "2016-09", "has_results": false, "last_update_posted_date": "2017-09-15", "last_synced_at": "2026-09-12T02:31:10.833Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01711593" }, { "nct_id": "NCT01268215", "title": "Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bronchopulmonary Dysplasia" ], "interventions": [ { "name": "Infasurf", "type": "DRUG" }, { "name": "Pulmicort", "type": "DRUG" }, { "name": "Sham", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "East Carolina University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "24 Weeks", "maximum_age": "28 Weeks", "sex": "ALL", "summary": "24 Weeks to 28 Weeks" }, "enrollment_count": 45, "start_date": "2010-07", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2010-12-29", "last_synced_at": "2026-09-12T02:31:10.833Z", "location_count": 1, "location_summary": "Greenville, North Carolina", "locations": [ { "city": "Greenville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01268215" }, { "nct_id": "NCT06450132", "title": "Changes in Eye Shape With Myopia Management Interventions", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Myopia" ], "interventions": [ { "name": "Atropine Ophthalmic", "type": "DRUG" }, { "name": "MiSight 1-day disposable contact lenses", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "21 Years to 30 Years" }, "enrollment_count": 75, "start_date": "2024-08-01", "completion_date": "2026-07-31", "has_results": false, "last_update_posted_date": "2026-01-27", "last_synced_at": "2026-09-12T02:31:10.833Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06450132" }, { "nct_id": "NCT03081858", "title": "Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Bladder Cancer Cell Transitional", "Non-Muscle Invasive Bladder Cancer", "Bladder Cancer", "Urinary Bladder", "Transitional Cell Carcinoma of the Bladder", "Urinary Bladder Neoplasms", "Urologic Neoplasms", "Urogenital Neoplasms", "Urinary Bladder Diseases", "Urologic Diseases" ], "interventions": [ { "name": "TSD-001", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lipac Oncology LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 15, "start_date": "2018-05-17", "completion_date": "2021-08-05", "has_results": true, "last_update_posted_date": "2025-06-27", "last_synced_at": "2026-09-12T02:31:10.833Z", "location_count": 5, "location_summary": "Tucson, Arizona • Bakersfield, California • Los Angeles, California + 2 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Hanover", "state": "Maryland" }, { "city": "Myrtle Beach", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03081858" }, { "nct_id": "NCT06176651", "title": "Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Dry Eye", "Dry Eye, Evaporative", "Dry Eye Disease", "Evaporative Dry Eye", "Evaporative Dry Eye Disease", "Kerato Conjunctivitis Sicca" ], "interventions": [ { "name": "Miebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gordon Schanzlin New Vision", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2023-09-21", "completion_date": "2024-04-05", "has_results": false, "last_update_posted_date": "2024-04-09", "last_synced_at": "2026-09-12T02:31:10.833Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06176651" }, { "nct_id": "NCT03931408", "title": "Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neurogenic Bladder", "Spinal Cord Injuries" ], "interventions": [ { "name": "Gentamicin Sulfate", "type": "DRUG" }, { "name": "Placebo instillation (saline alone)", "type": "OTHER" }, { "name": "No instillation", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Louisville", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2019-02-19", "completion_date": "2020-12-30", "has_results": true, "last_update_posted_date": "2025-01-29", "last_synced_at": "2026-09-12T02:31:10.833Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT03931408" } ] }